Australia markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.08-0.41 (-4.83%)
At close: 04:00PM EST
8.10 +0.02 (+0.25%)
After hours: 07:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous close8.49
Bid0.00 x 900
Ask0.00 x 900
Day's range7.96 - 8.52
52-week range7.13 - 19.83
Avg. volume2,018,041
Market cap629.931M
Beta (5Y monthly)0.71
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Anavex's (AVXL) Lead Alzheimer's Drug Meets Study Goal

    Top-line data from a phase IIb/III study shows that Anave's (AVXL) lead drug exhibited statistical and clinical improvement in cognition and function in patients with early Alzheimer's disease.

  • Motley Fool

    Is Anavex Life Sciences a Smart Stock to Buy Now?

    Shares of clinical-stage biotechnology company Anavex Life Sciences (NASDAQ: AVXL) recently shot higher. Investors reacting to great news for its Alzheimer's disease drug candidate, blarcamesine, drove the stock about 40% higher when the market opened on Friday, Dec. 2. Is Anavex Life Sciences a smart stock to buy now, or will the road ahead be a rocky one full of potholes?

  • Motley Fool

    Why Anavex Life Sciences Stock Is Surging Today

    The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate.